BeStock  
Stocks › Biotechnology › SLBT

SL Science SLBT

US equityMarket cap rank #3363Biotechnology
$1.51 −$0.01 (-0.66%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $1.50 -0.66%
Open$1.51
Prev close$1.52
Day range$1.50 – $1.57
Volume68.4K
Market cap$846.75M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-137.3x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -473.1x

Price / book94.4x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average 251.0x

#5281 of 5317 stocks by PB (1 = cheapest)

Price / sales385.4x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average 762.8x

#5022 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-2,400x-1,541x-682x178xJun '26Aug '26Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$1.74
Price vs. fair value-13.3%Trading below the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 94.38 – 251.00 2% (cheaper than usual) #5281 of 5317 (1 = cheapest)
PE -137.27 – -473.07 99% (pricier than usual) –
PS 385.37 – 762.79 2% (cheaper than usual) #5022 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$1.74
Economic moatNarrow
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on SLBT.

Leave a comment

Scroll to Top